CELLSEARCH CTC Test

About Cell Search

Cell Search commercializes the first and only FDA-cleared test for capturing and enumerating circulating tumor cells (CTCs) from a blood sample. Its CELLSEARCH® system is positioned as the gold standard for prognostic monitoring in metastatic breast, prostate, and colorectal cancer, providing actionable data on progression-free and overall survival. The company operates primarily through a diagnostics business model, offering its test kits and associated instrumentation to clinical laboratories. As a commercial-stage entity with an approved product, its focus is on market penetration and supporting clinical utility.

About Cell Search

Cell Search commercializes the first and only FDA-cleared test for capturing and enumerating circulating tumor cells (CTCs) from a blood sample. Its CELLSEARCH® system is positioned as the gold standard for prognostic monitoring in metastatic breast, prostate, and colorectal cancer, providing actionable data on progression-free and overall survival. The company operates primarily through a diagnostics business model, offering its test kits and associated instrumentation to clinical laboratories. As a commercial-stage entity with an approved product, its focus is on market penetration and supporting clinical utility.

About Cell Search

Cell Search commercializes the first and only FDA-cleared test for capturing and enumerating circulating tumor cells (CTCs) from a blood sample. Its CELLSEARCH® system is positioned as the gold standard for prognostic monitoring in metastatic breast, prostate, and colorectal cancer, providing actionable data on progression-free and overall survival. The company operates primarily through a diagnostics business model, offering its test kits and associated instrumentation to clinical laboratories. As a commercial-stage entity with an approved product, its focus is on market penetration and supporting clinical utility.

Therapeutic Areas